Colliding Epidemics and the Rise of Cryptococcosis
Abstract
:1. Introduction
2. Cryptococcosis in Association with Malignancy and Autoimmune Diseases
3. The Rise of Transplantation and Transplant Immunology
4. Cryptococcosis and HIV
5. Environmental Outbreaks
Region | Genotype (% Total Strains) | |||
---|---|---|---|---|
VGI | VGII | VGIII | VGIV | |
North America | 11 | 60 | 15 | 4 |
South America | 12 | 69 | 15 | 4 |
Europe | 70 | 30 | - | - |
Africa | 11 | 1 | 2 | 86 |
Asia | 73 | 19 | 5 | 3 |
Australasia | 65 | 31 | 7 | - |
6. Conclusions
Conflicts of Interest
References
- Casadevall, A.; Perfect, J.R. Introduction to the Pathogen. In Cryptococcus Neoformans; American Society for Microbiology (ASM) Press: Washington, DC, USA, 1998; pp. 1–27. [Google Scholar]
- Kampen, K.R. The discovery and early understanding of leukemia. Leuk. Res. 2012, 36, 6–13. [Google Scholar] [CrossRef] [PubMed]
- Freeman, W.; Weidman, F.D. Cystic blastomycosis of the cerebral gray matter. Arch. Neurol. Psychiatry 1923, 9, 589–603. [Google Scholar] [CrossRef]
- Gendel, B.R.; Ende, M.; Norman, S.L. Cryptococcosis: A review with special reference to apparent association with Hodgkin’s disease. Am. J. Med. 1950, 9, 343–355. [Google Scholar] [CrossRef]
- Dubin, I.N. The poverty of the immunological mechanism in patients with Hodgkin’s disease. Ann. Intern. Med. 1947, 27, 898–913. [Google Scholar] [PubMed]
- Collins, V.P.; Gellhorn, A.; Trimble, J.R. The coincidence of cryptococcosis and disease of the reticulo-endothelial and lymphatic systems. Cancer 1951, 4, 883–889. [Google Scholar] [CrossRef]
- Kaplan, M.H.; Rosen, P.P.; Armstrong, D. Cryptococcosis in a cancer hospital: Clinical and pathological correlates in forty-six patients. Cancer 1977, 39, 2265–2274. [Google Scholar] [CrossRef]
- Lepow, H.; Rubenstein, L.; Chu, F.; Shandra, J. A case of Cryptococcus neoformans meningoencephalitis complicating Boeck’s sarcoid. Pediatrics 1957, 19, 377–386. [Google Scholar] [PubMed]
- Pariser, S.; Littman, M.L.; Duffy, J.L. Cryptococcal meningo-encephalitis associated with systemic lupus erythematosus. J. Mt. Sinai Hosp. N. Y. 1961, 28, 550–561. [Google Scholar] [PubMed]
- Linden, I.H.; Steffen, C.G. Pulmonary cryptococcosis. Am. Rev. Tuberc. 1954, 69, 116–120. [Google Scholar] [PubMed]
- Goldstein, E.; Rambo, O.N. Cryptococcal infection following steroid therapy. Ann. Intern. Med. 1962, 56, 114–120. [Google Scholar] [CrossRef] [PubMed]
- Malheiro, L.; Lazzara, D.; Xerinda, S.; Pinheiro, M.D.; Sarmento, A. Cryptococcal meningoencephalitis in a patient with hyper immunoglobulin M (IgM) syndrome: A case report. BMC Res. Notes 2014, 7. [Google Scholar] [CrossRef] [PubMed]
- Alsum, Z.; Al-Saud, B.; Al-Ghonaium, A.; Bin Hussain, I.; Alsmadi, O.; Al-Mousa, H.; Ayas, M.; Al-Dhekri, H.; Arnaout, R.; Al-Muhsen, S. Disseminated cryptococcal infection in patient with novel JAK3 mutation severe combined immunodeficiency, with resolution after stem cell transplantation. Pediatr. Infect. Dis. J. 2012, 31, 204–206. [Google Scholar] [CrossRef] [PubMed]
- Muller-Ruchholtz, W. Glances at the history of transplantation immunology. Transplant. Proc. 1999, 31, 1443–1451. [Google Scholar] [CrossRef]
- Starzl, T.E.; Zinkernagel, R.M. Transplantation tolerance from a historical perspective. Nat. Rev. Immunol. 2001, 1, 233–239. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Russell, P.S.; Monaco, A.P. The biology of tissue transplantation. N. Engl. J. Med. 1964, 271, 664–671. [Google Scholar] [CrossRef] [PubMed]
- The Nobel Prize in Physiology or Medicine. 2015. Available online: http://www.nobelprize.org/nobel_prizes/medicine/laureates/ (accessed on 3 October 2015).
- Calne, R.Y.; White, D.J.; Thiru, S.; Evans, D.B.; McMaster, P.; Dunn, D.C.; Craddock, G.N.; Pentlow, B.D.; Rolles, K. Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet 1978, 2, 1323–1327. [Google Scholar] [CrossRef]
- Kino, T.; Hatanaka, H.; Hashimoto, M.; Nishiyama, M.; Goto, T.; Okuhara, M.; Kohsaka, M.; Aoki, H.; Imanaka, H. FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J. Antibiot. 1987, 40, 1249–1255. [Google Scholar] [CrossRef] [PubMed]
- Vezina, C.; Kudelski, A.; Sehgal, S.N. Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J. Antibiot. 1975, 28, 721–726. [Google Scholar] [CrossRef] [PubMed]
- Schlich, T. The origins of organ transplantation. Lancet 2011, 378, 1372–1373. [Google Scholar] [CrossRef]
- Linden, P.K. History of solid organ transplantation and organ donation. Crit. Care Clin. 2009, 25, 165–184. [Google Scholar] [CrossRef] [PubMed]
- Watson, C.J.; Dark, J.H. Organ transplantation: Historical perspective and current practice. Br. J. Anaesth. 2012, 108 (Suppl. S1), i29–i42. [Google Scholar] [CrossRef] [PubMed]
- Van Thiel, D.H.; Makowka, L.; Starzl, T.E. Liver transplantation: Where it’s been and where it’s going. Gastroenterol. Clin. N. Am. 1988, 17, 1–18. [Google Scholar] [CrossRef]
- Shapiro, A.M.; Lakey, J.R.; Ryan, E.A.; Korbutt, G.S.; Toth, E.; Warnock, G.L.; Kneteman, N.M.; Rajotte, R.V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 2000, 343, 230–238. [Google Scholar] [CrossRef] [PubMed]
- Park, C.G.; Bottino, R.; Hawthorne, W.J. Current status of islet xenotransplantation. Int. J. Surg. 2015. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Global Observatory on Donations and Transplantation. 2015. Available online: http://www.transplant-observatory.org/Pages/home.aspx (accessed on 3 October 2015).
- Davis, J.A.; Horn, D.L.; Marr, K.A.; Fishman, J.A. Central nervous system involvement in cryptococcal infection in individuals after solid organ transplantation or with AIDS. Transpl. Infect. Dis. 2009, 11, 432–437. [Google Scholar] [CrossRef] [PubMed]
- Baddley, J.W.; Schain, D.C.; Gupte, A.A.; Lodhi, S.A.; Kayler, L.K.; Frade, J.P.; Lockhart, S.R.; Chiller, T.; Bynon, J.S., Jr.; Bower, W.A. Transmission of Cryptococcus neoformans by Organ Transplantation. Clin. Infect. Dis. 2011, 52, e94–e98. [Google Scholar] [CrossRef] [PubMed]
- Sun, H.Y.; Alexander, B.D.; Lortholary, O.; Dromer, F.; Forrest, G.N.; Lyon, G.M.; Somani, J.; Gupta, K.L.; del Busto, R.; Pruett, T.L.; et al. Unrecognized pretransplant and donor-derived cryptococcal disease in organ transplant recipients. Clin. Infect. Dis. 2010, 51, 1062–1069. [Google Scholar] [CrossRef] [PubMed]
- Khan, A.; El-Charabaty, E.; El-Sayegh, S. Fungal infections in renal transplant patients. J. Clin. Med. Res. 2015, 7, 371–378. [Google Scholar] [CrossRef] [PubMed]
- Santos, T.; Aguiar, B.; Santos, L.; Romaozinho, C.; Tome, R.; Macario, F.; Alves, R.; Campos, M.; Mota, A. Invasive Fungal Infections after Kidney Transplantation: A Single-center Experience. Transplant. Proc. 2015, 47, 971–975. [Google Scholar] [CrossRef] [PubMed]
- Cicora, F.; Petroni, J.; Formosa, P.; Roberti, J. A rare case of Cryptococcus gattii pneumonia in a renal transplant patient. Transpl. Infect. Dis. 2015, 17, 463–466. [Google Scholar] [CrossRef] [PubMed]
- Singh, N.; Sifri, C.D.; Silveira, F.P.; Miller, R.; Gregg, K.S.; Huprikar, S.; Lease, E.D.; Zimmer, A.; Dummer, J.S.; Spak, C.W. Cryptococcosis in Patients with Cirrhosis of the Liver and Posttransplant Outcomes. Transplantation 2015, 99, 2132–2141. [Google Scholar] [CrossRef] [PubMed]
- Farber, S.A.; Micheletti, R.G. Cryptococcal meningitis presenting with headache and a pustular eruption in a heart transplant patient. Transpl. Infect. Dis. 2015, 17, 716–718. [Google Scholar] [CrossRef] [PubMed]
- Dall Bello, A.G.; Severo, C.B.; Schio, S.; Severo, L.C. First reported case of cellulitis due to Cryptococcus gattii in lung transplantation recipient: A case report. Dermatol. Online J. 2013, 19, 20395. [Google Scholar] [PubMed]
- Chaaban, S.; Wheat, L.J.; Assi, M. Cryptococcal meningitis post autologous stem cell transplantation. Transpl. Infect. Dis. 2014, 16, 473–476. [Google Scholar] [CrossRef] [PubMed]
- Biancheri, D.; Kanitakis, J.; Bienvenu, A.L.; Picot, S.; Morelon, E.; Faure, M.; Euvrard, S. Cutaneous cryptococcosis in solid organ transplant recipients: Epidemiological, clinical, diagnostic and therapeutic features. Eur. J. Dermatol. 2012, 22, 651–657. [Google Scholar] [PubMed]
- Osawa, R.; Alexander, B.D.; Forrest, G.N.; Lyon, G.M.; Somani, J.; del Busto, R.; Pruett, T.L.; Sifri, C.D.; Limaye, A.P.; Klintmalm, G.B. Geographic differences in disease expression of cryptococcosis in solid organ transplant recipients in the United States. Ann. Transplant. 2010, 15, 77–83. [Google Scholar] [PubMed]
- Singh, N.; Lortholary, O.; Alexander, B.D.; Gupta, K.L.; John, G.T.; Pursell, K.; Munoz, P.; Klintmalm, G.B.; Stosor, V.; del Busto, R. An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients. Clin. Infect. Dis. 2005, 40, 1756–1761. [Google Scholar] [CrossRef] [PubMed]
- Sun, H.Y.; Singh, N. Immune reconstitution inflammatory syndrome in non-HIV immunocompromised patients. Curr. Opin. Infect. Dis. 2009, 22, 394–402. [Google Scholar] [CrossRef] [PubMed]
- Sun, H.Y.; Singh, N. Opportunistic infection-associated immune reconstitution syndrome in transplant recipients. Clin. Infect. Dis. 2011, 53, 168–176. [Google Scholar] [CrossRef] [PubMed]
- Sun, H.Y.; Alexander, B.D.; Huprikar, S.; Forrest, G.N.; Bruno, D.; Lyon, G.M.; Wray, D.; Johnson, L.B.; Sifri, C.D.; Razonable, R.R. Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: Implications for the management of immunosuppression. Clin. Infect. Dis. 2015, 60, 36–44. [Google Scholar] [CrossRef] [PubMed]
- Park, B.J.; Wannemuehler, K.A.; Marston, B.J.; Govender, N.; Pappas, P.G.; Chiller, T.M. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009, 23, 525–530. [Google Scholar] [CrossRef] [PubMed]
- Lawn, S.D.; Harries, A.D.; Anglaret, X.; Myer, L.; Wood, R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2008, 22, 1897–1908. [Google Scholar] [CrossRef] [PubMed]
- Ojikutu, B.O.; Zheng, H.; Walensky, R.P.; Lu, Z.; Losina, E.; Giddy, J.; Freedberg, K.A. Predictors of mortality in patients initiating antiretroviral therapy in Durban, South Africa. S. Afr. Med. J. 2008, 98, 204–208. [Google Scholar] [PubMed]
- McKenney, J.; Smith, R.M.; Chiller, T.M.; Detels, R.; French, A.; Margolick, J.; Klausner, J.D.; Centers for Disease Control and Prevention. Prevalence and Correlates of Cryptococcal Antigen Positivity Among AIDS Patients—United States, 1986–2012. Morb. Mortal. Wkly. Rep. 2014, 63, 585–587. [Google Scholar]
- Mirza, S.A.; Phelan, M.; Rimland, D.; Graviss, E.; Hamill, R.; Brandt, M.E.; Gardner, T.; Sattah, M.; de Leon, G.P.; Baughman, W.; Hajjeh, R.A. The changing epidemiology of cryptococcosis: An update from population-based active surveillance in 2 large metropolitan areas, 1992–2000. Clin. Infect. Dis. 2003, 36, 789–794. [Google Scholar] [CrossRef] [PubMed]
- Pyrgos, V.; Seitz, A.E.; Steiner, C.A.; Prevots, D.R.; Williamson, P.R. Epidemiology of cryptococcal meningitis in the U.S.: 1997–2009. PLoS ONE 2013, 8, e56269. [Google Scholar] [CrossRef] [PubMed]
- Mwaba, P.; Mwansa, J.; Chintu, C.; Pobee, J.; Scarborough, M.; Portsmouth, S.; Zumla, A. Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions. Postgrad. Med. J. 2001, 77, 769–773. [Google Scholar] [CrossRef] [PubMed]
- Bennett, J.E.; Dismukes, W.E.; Duma, R.J.; Medoff, G.; Sande, M.A.; Gallis, H.; Leonard, J.; Fields, B.T.; Bradshaw, M.; Haywood, H. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. N. Engl. J. Med. 1979, 301, 126–131. [Google Scholar] [CrossRef] [PubMed]
- Van der Horst, C.M.; Saag, M.S.; Cloud, G.A.; Hamill, R.J.; Graybill, J.R.; Sobel, J.D.; Johnson, P.C.; Tuazon, C.U.; Kerkering, T.; Moskovitz, B.L.; et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N. Engl. J. Med. 1997, 337, 15–21. [Google Scholar] [CrossRef] [PubMed]
- Perfect, J.R.; Dismukes, W.E.; Dromer, F.; Goldman, D.L.; Graybill, J.R.; Hamill, R.J.; Harrison, T.S.; Larsen, R.A.; Lortholary, O.; Nguyen, M.H. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin. Infect. Dis. 2010, 50, 291–322. [Google Scholar] [CrossRef] [PubMed]
- Day, J.N.; Chau, T.T.; Wolbers, M.; Mai, P.P.; Dung, N.T.; Mai, N.H.; Phu, N.H.; Nghia, H.D.; Phong, N.D.; Thai, C.Q.; et al. Combination antifungal therapy for cryptococcal meningitis. N. Engl. J. Med. 2013, 368, 1291–1302. [Google Scholar] [CrossRef] [PubMed]
- Bicanic, T.; Wood, R.; Meintjes, G.; Rebe, K.; Brouwer, A.; Loyse, A.; Bekker, L.G.; Jaffar, S.; Harrison, T. High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: A randomized trial. Clin. Infect. Dis. 2008, 47, 123–130. [Google Scholar] [CrossRef] [PubMed]
- Bicanic, T.; Muzoora, C.; Brouwer, A.E.; Meintjes, G.; Longley, N.; Taseera, K.; Rebe, K.; Loyse, A.; Jarvis, J.; Bekker, L.G.; et al. Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: Analysis of a combined cohort of 262 patients. Clin. Infect. Dis. 2009, 49, 702–709. [Google Scholar] [CrossRef] [PubMed]
- Brouwer, A.E.; Rajanuwong, A.; Chierakul, W.; Griffin, G.E.; Larsen, R.A.; White, N.J.; Harrison, T.S. Combination antifungal therapies for HIV-associated cryptococcal meningitis: A randomised trial. Lancet 2004, 363, 1764–1767. [Google Scholar] [CrossRef]
- Jarvis, J.N.; Meintjes, G.; Rebe, K.; Williams, G.N.; Bicanic, T.; Williams, A.; Schutz, C.; Bekker, L.G.; Wood, R.; Harrison, T.S. Adjunctive interferon-gamma immunotherapy for the treatment of HIV-associated cryptococcal meningitis: A randomized controlled trial. AIDS 2012, 26, 1105–1113. [Google Scholar] [CrossRef] [PubMed]
- Jarvis, J.N.; Bicanic, T.; Loyse, A.; Namarika, D.; Jackson, A.; Nussbaum, J.C.; Longley, N.; Muzoora, C.; Phulusa, J.; Taseera, K. Determinants of Mortality in a Combined Cohort of 501 Patients with HIV-Associated Cryptococcal Meningitis: Implications for Improving Outcomes. Clin. Infect. Dis. 2014, 58, 736–745. [Google Scholar] [CrossRef] [PubMed]
- Boulware, D.R.; Bonham, S.C.; Meya, D.B.; Wiesner, D.L.; Park, G.S.; Kambugu, A.; Janoff, E.N.; Bohjanen, P.R. Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome. J. Infect. Dis. 2010, 202, 962–970. [Google Scholar] [CrossRef] [PubMed]
- Boulware, D.R.; Meya, D.B.; Bergemann, T.L.; Wiesner, D.L.; Rhein, J.; Musubire, A.; Lee, S.J.; Kambugu, A.; Janoff, E.N.; Bohjanen, P.R. Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: A prospective cohort study. PLoS Med. 2010, 7, e1000384. [Google Scholar] [CrossRef] [PubMed]
- Boulware, D.R.; Meya, D.B.; Muzoora, C.; Rolfes, M.A.; Hullsiek, K.H.; Musubire, A.; Taseera, K.; Nabeta, H.W.; Schutz, C.; Williams, D.A.; et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. N. Engl. J. Med. 2014, 370, 2487–2498. [Google Scholar] [CrossRef] [PubMed]
- Meya, D.B.; Manabe, Y.C.; Castelnuovo, B.; Cook, B.A.; Elbireer, A.M.; Kambugu, A.; Kamya, M.R.; Bohjanen, P.R.; Boulware, D.R. Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count ≤ 100 cells/µL who start HIV therapy in resource-limited settings. Clin. Infect. Dis. 2010, 51, 448–455. [Google Scholar] [CrossRef] [PubMed]
- Pappas, P.G.; Chetchotisakd, P.; Larsen, R.A.; Manosuthi, W.; Morris, M.I.; Anekthananon, T.; Sungkanuparph, S.; Supparatpinyo, K.; Nolen, T.L.; Zimmer, L.O.; et al. A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis. Clin. Infect. Dis. 2009, 48, 1775–1783. [Google Scholar] [CrossRef] [PubMed]
- Pappas, P.G.; Bustamante, B.; Ticona, E.; Hamill, R.J.; Johnson, P.C.; Reboli, A.; Aberg, J.; Hasbun, R.; Hsu, H.H. Recombinant interferon-gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis. J. Infect. Dis. 2004, 189, 2185–2191. [Google Scholar] [PubMed]
- Bicanic, T.; Brouwer, A.E.; Meintjes, G.; Rebe, K.; Limmathurotsakul, D.; Chierakul, W.; Teparrakkul, P.; Loyse, A.; White, N.J.; Wood, R.; Jaffar, S.; Harrison, T. Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures. AIDS 2009, 23, 701–706. [Google Scholar] [CrossRef] [PubMed]
- Rolfes, M.A.; Hullsiek, K.H.; Rhein, J.; Nabeta, H.W.; Taseera, K.; Schutz, C.; Musubire, A.; Rajasingham, R.; Williams, D.A.; Thienemann, F.; et al. The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis. Clin. Infect. Dis. 2014, 59, 1607–1614. [Google Scholar] [CrossRef] [PubMed]
- Shelburne, S.A., III; Darcourt, J.; White, A.C., Jr.; Greenberg, S.B.; Hamill, R.J.; Atmar, R.L.; Visnegarwala, F. The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin. Infect. Dis. 2005, 40, 1049–1052. [Google Scholar] [CrossRef] [PubMed]
- Chang, C.C.; Dorasamy, A.A.; Gosnell, B.I.; Elliott, J.H.; Spelman, T.; Omarjee, S.; Naranbhai, V.; Coovadia, Y.; Ndung'u, T.; Moosa, M.Y.; et al. Clinical and mycological predictors of Cryptococcosis-associated Immune reconstitution inflammatory syndrome (C-IRIS). AIDS 2013, 27, 2089–2099. [Google Scholar] [CrossRef] [PubMed]
- Boulware, D.R.; Meya, D.B.; Bergemann, T. Inflammatory Biomarkers in Serum Predict HIV Immune Reconstitution Inflammatory Syndrome and Death after Cryptococcal Meningitis. In Proceedings of the 16th Conference on Retroviruses and Opportunistic Infections (CROI), Montreal, QC, Canada, 8–11 February 2009.
- Chang, C.C.; Lim, A.; Omarjee, S.; Levitz, S.M.; Gosnell, B.I.; Spelman, T.; Elliott, J.H.; Carr, W.H.; Moosa, M.Y.; Ndung'u, T.; et al. Cryptococcosis-IRIS is associated with lower Cryptococcus-specific IFN-gamma responses before antiretroviral therapy but not higher T-cell responses during therapy. J. Infect. Dis. 2013, 208, 898–906. [Google Scholar] [CrossRef] [PubMed]
- Chang, C.C.; Omarjee, S.; Lim, A.; Spelman, T.; Gosnell, B.I.; Carr, W.H.; Elliott, J.H.; Moosa, M.Y.; Ndung'u, T.; French, M.A.; et al. Chemokine levels and chemokine receptor expression in blood and the CSF of HIV-infected patients with cryptococcal meningitis and C-IRIS. J. Infect. Dis. 2013, 208, 1604–1612. [Google Scholar] [CrossRef] [PubMed]
- Jarvis, J.N.; Casazza, J.P.; Stone, H.H.; Meintjes, G.; Lawn, S.D.; Levitz, S.M.; Harrison, T.S.; Koup, R.A. The phenotype of the Cryptococcus-specific CD4+ memory T-cell response is associated with disease severity and outcome in HIV-associated cryptococcal meningitis. J. Infect. Dis. 2013, 207, 1817–1828. [Google Scholar] [CrossRef] [PubMed]
- UNAIDS 2014: Fact Sheet. 2015. Available online: http://www.unaids.org/en/resources/documents/2015/20150714_factsheet (accessed on 3 October 2015).
- Garcia-Solache, M.A.; Casadevall, A. Global warming will bring new fungal diseases for mammals. MBio 2010, 1. [Google Scholar] [CrossRef] [PubMed]
- Perfect, J.R. Cryptococcus neoformans: The yeast that likes it hot. FEMS Yeast Res. 2006, 6, 463–468. [Google Scholar] [CrossRef] [PubMed]
- Raffa, R.B.; Eltoukhy, N.S.; Raffa, K.F. Implications of climate change (global warming) for the healthcare system. J. Clin. Pharm. Ther. 2012, 37, 502–504. [Google Scholar] [CrossRef] [PubMed]
- Benedict, K.; Park, B.J. Invasive fungal infections after natural disasters. Emerg. Infect. Dis. 2014, 20, 349–355. [Google Scholar] [CrossRef] [PubMed]
- Kwon-Chung, K.J.; Bennett, J.E. Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am. J. Epidemiol. 1984, 120, 123–130. [Google Scholar] [PubMed]
- Stephen, C.; Lester, S.; Black, W.; Fyfe, M.; Raverty, S. Multispecies outbreak of cryptococcosis on southern Vancouver Island, British Columbia. Can. Vet. J. 2002, 43, 792–794. [Google Scholar] [PubMed]
- Galanis, E.; MacDougall, L.; Kidd, S.; Morshed, M. British Columbia Cryptococcus gattii Working Group. Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999–2007. Emerg. Infect. Dis. 2010, 16, 251–257. [Google Scholar] [CrossRef] [PubMed]
- Hagen, F.; Ceresini, P.C.; Polacheck, I.; Ma, H.; van Nieuwerburgh, F.; Gabaldón, T.; Kagan, S.; Pursall, E.R.; Hoogveld, H.L.; van Iersel, L.J.; et al. Ancient dispersal of the human fungal pathogen Cryptococcus gattii from the Amazon rainforest. PLoS ONE 2013, 8, e71148. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Centers for Disease Control and Prevention. Emergence of Cryptococcus gattii—Pacific Northwest, 2004–2010. Ann. Emerg. Med. 2011, 57, 60–62. [Google Scholar]
- Harris, J.R.; Lockhart, S.R.; Sondermeyer, G.; Vugia, D.J.; Crist, M.B.; D'Angelo, M.T.; Sellers, B.; Franco-Paredes, C.; Makvandi, M.; Smelser, C.; et al. Cryptococcus gattii infections in multiple states outside the US Pacific Northwest. Emerg. Infect. Dis. 2013, 19, 1620–1626. [Google Scholar] [CrossRef] [PubMed]
- Hagen, F.; van Assen, S.; Luijckx, G.J.; Boekhout, T.; Kampinga, G.A. Activated dormant Cryptococcus gattii infection in a Dutch tourist who visited Vancouver Island (Canada): A molecular epidemiological approach. Med. Mycol. 2010, 48, 528–531. [Google Scholar] [CrossRef] [PubMed]
- Hagen, F.; Colom, M.F.; Swinne, D.; Tintelnot, K.; Latta, R.; Montagna, M.T.; Torres-Rodriguez, J.M.; Cogliati, M.; Velegraki, A.; Burggraaf, A.; et al. Autochthonous and dormant Cryptococcus gattii infections in Europe. Emerg. Infect. Dis. 2012, 18, 1618–1624. [Google Scholar] [CrossRef] [PubMed]
- Okamoto, K.; Hatakeyama, S.; Itoyama, S.; Nukui, Y.; Yoshino, Y.; Kitazawa, T.; Yotsuyanagi, H.; Ikeda, R.; Sugita, T.; Koike, K. Cryptococcus gattii genotype VGIIa infection in man, Japan, 2007. Emerg. Infect. Dis. 2010, 16, 1155–1157. [Google Scholar] [CrossRef] [PubMed]
- Chen, S.C.; Meyer, W.; Sorrell, T.C. Cryptococcus gattii infections. Clin. Microbiol. Rev. 2014, 27, 980–1024. [Google Scholar] [CrossRef] [PubMed]
© 2015 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons by Attribution (CC-BY) license ( http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Chang, C.C.; Chen, S.C.-A. Colliding Epidemics and the Rise of Cryptococcosis. J. Fungi 2016, 2, 1. https://doi.org/10.3390/jof2010001
Chang CC, Chen SC-A. Colliding Epidemics and the Rise of Cryptococcosis. Journal of Fungi. 2016; 2(1):1. https://doi.org/10.3390/jof2010001
Chicago/Turabian StyleChang, Christina C., and Sharon C.-A. Chen. 2016. "Colliding Epidemics and the Rise of Cryptococcosis" Journal of Fungi 2, no. 1: 1. https://doi.org/10.3390/jof2010001